Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK1278863 in Peripheral Artery Disease
NCT02135848Phase 2Completed
- Sponsor
- GSK
- Start
- Oct 2010
- Primary completion
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of daprodustat in peripheral artery disease (PAD), sponsored by GSK. Started Oct 2010; status: completed.
02
Drugs
daprodustat
03
Conditions
peripheral artery disease (PAD)
Beyond the preview
Go deeper on NCT02135848.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02135848.